CTRI/2020/06/025914尚未招募未知
Treat to target strategy in active ulcerative colitis patient: a randomized control trial
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of active ulcerative colitis presenting within 1 year of disease onset.
- •2.Patients with left sided or pancolitis.
- •3.Patients who have not received any dose of steroid, immune-modulators or biologics.
- •4.Patient giving written informed consent.
排除标准
- •1.Age < 18 years, >75 years.
- •2.Patients with only rectal involvement (E1 disease).
- •3.Patients presenting with acute severe ulcerative colitis requiring hospitalization.
- •4.Patients with indeterminate form of colitis.
- •5.Pregnancy
- •Patient with concomitant gastrointestinal infection.
- •Patients infected with HBV, HCV or HIV.
- •Other major co-morbid conditions like acute myocardial infarction, chronic kidney disease or chronic liver disease.
研究者
相似试验
已完成
不适用
Antibiotic combination therapy for ulcerative colitisulcerative colitisJPRN-UMIN000017844Shiga University of Medical Science20
已完成
3 期
Remission maintenance treatment of ulcerative colitis with tacrolimus in azathioprine-intolerant patients: a randomized comparative trial of 5-aminosalicylic acid (5-ASA) monotherapy versus 5-ASA and tacrolimus combination therapy.JPRN-UMIN000003785Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine80
进行中（未招募）
1 期
SB012 for the treatment of active ulcerative colitis: a clinical study in early development (phase IIa), conducted in several study centres, with random assignment of patients to active treatment or placebo, to investigate the efficacy, pharmacokinetics, tolerability, and safety of SB012 enema administered once dailyActive ulcerative colitisEUCTR2013-004599-36-DEsterna biologicals GmbH & Co. KG18
已完成
不适用
Improvement of treatment in ulcerative colitis, severe case and moderate case close to severe case, by early use of infliximabulcerative colitisJPRN-UMIN000020402IBD Relapse Prevention Team50
招募中
不适用
Better control and treatment of Ulcerative Colitis (UC) by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsiesUlcerative ColitisNL-OMON54471Radboud Universitair Medisch Centrum40